Safety Testing of Adding Nivolumab to Chemotherapy in Patients With Intermediate and High-Risk Local-Regionally Advanced Head and Neck Cancer
Clinical trial NCT02764593 · COMPLETED
Trial details
- NCT number
- NCT02764593
- Sponsor
- RTOG Foundation, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2018-09-25
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.